<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Exploration of 3-methylisoquinoline-4-carbonitriles as Protein Kinase A inhibitors of Plasmodium Falciparum

avondale-bepress.context-key9758971
avondale-bepress.submission-pathsci_math_papers/85
avondale.facultyScience
avondale.reporting.isPeerReviewedPeer Reviewed
avondale.reporting.versionPublished Version
dc.contributor.authorAbbott, Belinda M.
dc.contributor.authorWilson, David J.
dc.contributor.authorGilson, Paul R.
dc.contributor.authorCrabb, Brendan S.
dc.contributor.authorPrinz, Boris
dc.contributor.authorHarvey, Katherine L.
dc.contributor.authorBuskes, Melissa J.
dc.date.accessioned2023-11-01T00:24:42Z
dc.date.available2023-11-01T00:24:42Z
dc.date.issued2016-06-01
dc.date.submitted2017-02-27T19:27:01Z
dc.description.abstract<p>A series of isoquinolines have been evaluated in a homology model of Plasmodium falciparum Protein Kinase A (PfPKA) using molecular dynamics. Synthesis of these compounds was then undertaken to investigate their structure–activity relationships. One compound was found to inhibit parasite growth in an in vitro assay and provides a lead to further develop 3-methylisoquinoline-4-carbonitriles as antimalarial compounds. Development of a potent and selective PfPKA inhibitor would provide a useful tool to shed further insight into the mechanisms enabling malaria parasites to establish infection.</p>
dc.identifier.citation<p>Buskes, M. J., Harvey, K. L., Prinz, B., Crabb, B. S., Gilson, P. R., Wilson, D. J., & Abbott, B. M. (2016). Exploration of 3-methylisoquinoline-4-carbonitriles as protein kinase A inhibitors of Plasmodium falciparum. <em>Bioorganic & Medicinal Chemistry, 24</em>(11), 2389-2396. doi:10.1016/j.bmc.2016.03.048</p>
dc.identifier.doihttps://doi.org/10.1016/j.bmc.2016.03.048
dc.identifier.issn0968-0896
dc.identifier.urihttps://research.avondale.edu.au/handle/1897/09758971
dc.language.isoen_us
dc.provenance<p>This article was originally published as:</p> <p>Buskes, M. J., Harvey, K. L., Prinz, B., Crabb, B. S., Gilson, P. R., Wilson, D. J., & Abbott, B. M. (2016). Exploration of 3-methylisoquinoline-4-carbonitriles as protein kinase A inhibitors of Plasmodium falciparum. <em>Bioorganic & Medicinal Chemistry, 24</em>(11), 2389-2396. doi: 10.1016/j.bmc.2016.03.048</p> <p>ISSN: 0968-0896</p>
dc.relation.ispartofBioorganic & Medicinal Chemistry
dc.rights<p>Due to copyright restrictions this article is unavailable for download.</p> <p>Copyright © 2016 Published by Elsevier Ltd. All rights reserved.</p> <p>Staff and Students of Avondale College may access the full text of this article via Library PRIMO search <a href="https://avondale-primo.hosted.exlibrisgroup.com/primo-explore/search?vid=AVN&lang=en_US">here</a>.</p>
dc.subjectIsoquinolines; Protein Kinase A; Antimalarials; Inhibitors
dc.titleExploration of 3-methylisoquinoline-4-carbonitriles as Protein Kinase A inhibitors of Plasmodium Falciparum
dc.typeJournal Article

Files

Avondale University acknowledges our Sovereign God as Creator and Provider of all things. We respectfully acknowledge the Awabakal and Darramuragal people as the traditional custodians of the lands on which we live, work, study and worship across our Lake Macquarie and Sydney campuses. We pay our respects to Elders past, present and emerging, and extend that respect to all First Nations People.

Aboriginal Peoples are advised the Library Collection contains images, voices and names of deceased people in physical and online resources. The Library recognises the significance of the traditional cultural knowledges contained within its Collection. The Library acknowledge some materials contain language that may not reflect current attitudes, was published without consent or recognition, or, is offensive. These materials reflect the views of the authors and/or the period in which they were produced and do not represent the views of the Library.

Avondale University is a member of the worldwide Seventh-day Adventist system of universities and colleges.

CRICOS Provider No.: 02731D. RTO: 91191. TEQSA: PRV12015. ABN: 53 108 186 401.

© Avondale University Ltd 2026